Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael Egholm

Michael Egholm is recorded as CEO and Board Member at Standard Biotools Inc. (LAB). The proxy statement of Standard Biotools Inc. reports total compensation of $8,823,502 for Michael Egholm in fiscal 2025, including a base salary of $680,256. Disclosed compensation is on record for 4 fiscal years. Michael Egholm has spoken on 13 earnings calls across 1 company, most recently for Standard Biotools Inc. on May 6, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Standard Biotools Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Standard Biotools Inc. (LAB) $680,256 $8,823,502
2024 Standard Biotools Inc. (LAB) $686,250 $8,337,044
2023 Standard Biotools Inc. (LAB) $596,667 $1,931,088
2022 Standard Biotools Inc. (LAB) $373,106 $15,895,848

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.